May 5, 2020 / 9:33 PM / a month ago

BRIEF-Agile Therapeutics Reports First Quarter 2020 Financial Results

May 5 (Reuters) - Agile Therapeutics Inc:

* AGILE THERAPEUTICS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS

* Q1 LOSS PER SHARE $0.10

* Q1 EARNINGS PER SHARE ESTIMATE $-0.09 — REFINITIV IBES DATA

* 93.9 MILLION IN CASH AND CASH EQUIVALENTS AS OF MARCH 31, 2020

* EXPECTS OPERATING EXPENSES FOR FULL YEAR 2020 TO BE IN RANGE OF $52.0 MILLION TO $56.0 MILLION

* NET REVENUE IN Q4 OF 2020, REFLECTING INITIAL LAUNCH OF TWIRLA, IS EXPECTED TO BE IN RANGE OF $4.0 MILLION TO $6.0 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below